Ensysce Biosciences, Inc.

Historical 13F Holders

Symbol: ENSC
CUSIP: 293602405
All holders as of: Q3 2024
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 293602405 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Anson Funds Management LP 13G/A	2.1%	411,681	13G/A	2/14/2025 Event 12/31/2024
Anson Funds Management LP	2.1%	411,681
Anson Management GP LLC	2.1%	411,681
Tony Moore	2.1%	411,681
Anson Advisors Inc.	2.1%	411,681
Amin Nathoo	2.1%	411,681
Moez Kassam	2.1%	411,681
RA Capital Management, L.P. 13G/A	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.	0%	0
Peter Kolchinsky	0%	0
Rajeev Shah	0%	0
RA Capital Healthcare Fund, L.P.	0%	0

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2024 Q3	14	2.42 M	$581 k	$0
2024 Q2	11	499 k	$253 k	$0
2024 Q1	10	300 k	$237 k	$0
2023 Q4	8	52.7 k	$56.0 k	$0
2023 Q3	12	168 k	$231 k	$0
2023 Q2	9	396 k	$714 k	$0
2023 Q1	8	21.0 k	$101 k	$0